Vision in Scientific and Medical Publishing. Journal information and publication guidance. Flexible and measurable access options. Subject-specific resources for the medical community. Market insight and communications support. Series in our eBook collection.

16-18 November 2016 Munich, Germany. Focuses exclusively on how to deliver maximum clinical benefit through immune checkpoint monotherapy and combinations. Incorporating insights from Bristol-Myers Squibb. Attend this Immune Checkpoint Inhibitor event and fast track your immune-checkpoint development.

Returning for the third year, ICI Boston 2017. Is the only conference that focuses exclusively on delivering maximum clinical benefit through immune checkpoint monotherapy and combinations. Merck, BMS, Genentech, MedImmune, Novartis. And transform the success of your immuno-oncology approach.

Is the leading cause of cancer death worldwide. It is difficult to detect in its early stages, as well as understand and treat effectively. Rise in new candidates in 2015. VP, Director, Head.

An exclusive, annual biopharma summit providing insights into the research and development of cutting edge treatments for Breast Cancer and a networking forum for precision medicine leaders in this space. Breast Cancer is the most commonly occurring cancer in women, and is also the second leading cause of cancer death. Receives the largest amount of spending across all cancer types, and represents the largest opportunity for developers. VP, Director, Head.